# MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

> **NCT02733887** · NA · UNKNOWN · sponsor: **Guangxi Medical University** · enrollment: 66 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **DEVICE:** magnetic resonance imaging
- **DEVICE:** positron emission tomography/computed tomography
- **RADIATION:** fludeoxyglucose F 18

## Key facts

- **NCT ID:** NCT02733887
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2017-06
- **Final completion:** —
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2016-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02733887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02733887, "MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02733887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*